XML 39 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-Based Compensation (Tables)
 9 Months Ended
Nov. 03, 2018
Schedule of Restricted Stock Unit Activity
The following table summarizes activity for restricted stock units for the thirty-nine weeks ended November 3, 2018:
 
Service-based Restricted
Stock Units
 
Performance-based Restricted
Stock Units
 
Market-based Restricted
Stock Units
 
Number of 
Underlying
Shares (1)
 
Weighted-
Average Grant
Date Fair Value
 
Number of 
Underlying
Shares
 
Weighted-
Average Grant
Date Fair Value
 
Number of 
Underlying
Shares
 
Weighted-
Average Grant
Date Fair Value
Unvested at February 3, 2018
2,520,160

 
$
15.35

 
690,174

 
$
11.82

 
383,980

 
$
16.50

Granted
764,213

 
21.79

 
197,979

 
21.77

 
142,014

 
33.69

Adjustments for performance achievement
—

 
—

 
(43,999
)
 
20.10

 
(36,817
)
 
19.04

Vested
(923,378
)
 
17.19

 
—

 
—

 
(7,185
)
 
19.04

Forfeited
(154,812
)
 
15.41

 
(12,998
)
 
12.17

 
(12,999
)
 
17.28

Unvested at November 3, 2018
2,206,183

 
$
16.83

 
831,156

 
$
13.74

 
468,993

 
$
21.45



(1) 
Includes 449,923 unvested restricted stock units as of November 3, 2018, subject to vesting requirements related to the achievement of certain performance metrics, such as operating income and net income, for the fiscal year immediately preceding the vesting date. Holders of these restricted stock units have the opportunity to earn back one or more installments of the award if the cumulative performance requirements are met in a subsequent year. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at 100% of their target vesting amount in the table above.
Schedule of Stock Appreciation Rights Activity
Stock appreciation rights

The following table summarizes stock appreciation rights activity for the thirty-nine weeks ended November 3, 2018:
 
Number of
Underlying
Shares
 
Weighted-Average
Exercise Price
 
Aggregate
Intrinsic Value
 
Weighted-Average
Remaining
Contractual Life (years)
Outstanding at February 3, 2018
3,010,720

 
$
49.35

 
 
 
 
Granted
—

 
—

 
 
 
 
Exercised
(50,190
)
 
22.21

 
 
 
 
Forfeited or expired
(1,903,746
)
 
56.65

 
 
 
 
Outstanding at November 3, 2018
1,056,784

 
$
37.68

 
$
15,525

 
4.0
Stock appreciation rights exercisable at November 3, 2018
965,488

 
$
39.09

 
$
11,644

 
3.8
Stock appreciation rights expected to become exercisable in the future as of November 3, 2018
87,897

 
$
22.85

 
$
3,460

 
6.4

As of November 3, 2018, there was $0.3 million of total unrecognized compensation cost related to stock appreciation rights. The unrecognized compensation cost is expected to be recognized over a weighted-average period of 3 months.

The grant date fair value of stock appreciation rights that were exercised during the thirty-nine weeks ended November 3, 2018 and October 28, 2017 was $1.3 million and $2.2 million, respectively.
Schedule of Stock Option Activity
Stock options

The following table summarizes stock option activity for the thirty-nine weeks ended November 3, 2018:
 
Number of
Underlying
Shares
 
Weighted-Average
Exercise Price
 
Aggregate
Intrinsic Value
 
Weighted-Average
Remaining
Contractual Life (years)
Outstanding at February 3, 2018
87,200

 
$
78.20

 
 
 
 
Granted
—

 
—

 
 
 
 
Exercised
—

 
—

 
 
 
 
Forfeited or expired
(87,200
)
 
78.20

 
 
 
 
Outstanding at November 3, 2018
—

 
$
—

 
$
—

 
—

Stock options exercisable at November 3, 2018
—

 
$
—

 
$
—

 
—


As of November 3, 2018, there was no unrecognized compensation cost related to stock options.
Market-based restricted stock units [Member]  
Schedule of Weighted-Average Estimated Fair Value and Assumptions of Restricted Stock Units with Market Vesting Conditions
The weighted-average assumptions used for market-based restricted stock units in the Monte Carlo simulation during the thirty-nine weeks ended November 3, 2018 and October 28, 2017 were as follows:
 
November 3, 2018
 
October 28, 2017
Grant date market price
$
23.59

 
$
11.43

Fair value
$
33.69

 
$
11.79

Assumptions:
 
 
 
Price volatility
54
%
 
47
%
Expected term (years)
2.9

 
2.9

Risk-free interest rate
2.4
%
 
1.5
%
Dividend yield
3.4
%
 
7.0
%
Average volatility of peer companies
37.4
%
 
35.2
%
Average correlation coefficient of peer companies
0.2709

 
0.2664